QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) and DiaSorin (FTSE Italy Mid Cap: DIA) today appear the addition of an automated, CE-marked workflow for QIAGEN’s QuantiFERON-TB Gold Plus Blood Collection Tubes (QFT-Plus BCT) and a atypical DiaSorin LIAISON Analysis on broadly acclimated immunodiagnostic instruments from DiaSorin. Laboratories in Europe and added markets will now be able to action QFT-Plus BCT, the fourth-generation avant-garde gold accepted for abeyant tuberculosis (TB) detection, with DiaSorin’s flexible, able LIAISON systems. Availability is planned for the United States in 2019 and China in 2020.
The LIAISON QuantiFERON-TB Plus Analysis was developed in a affiliation amid QIAGEN and DiaSorin to advice abode accelerating about-face of the all-around abeyant TB testing bazaar to the avant-garde blood-based QuantiFERON technology. The barrage offers LIAISON barter efficient, high-throughput apprehension with QFT-Plus as allotment of the system’s ample agreeable menu, and QFT-Plus barter will accretion an advantage for abounding automation of class administration to abutment TB ascendancy efforts. More than 7,000 LIAISON systems accept been placed worldwide, primarily in hospital laboratories.
“We are admiring to action barter this compelling, automatic band-aid for the LIAISON QuantiFERON-TB Plus Test, enabling an bigger workflow of the world’s arch analysis for abeyant TB infection. Increasingly, accessible
13 Various Ways To Do Blood Collection Tubes And Tests Chart | Blood Collection Tubes And Tests Chart – blood collection tubes and tests chart
| Welcome to the blog, in this period I’ll teach you with regards to blood collection tubes and tests chart